Oriol Manuel
Experienced in Toxocariasis

Oriol Manuel

Infectious Disease
Lausanne, VD, CH 
Experienced in Toxocariasis
Lausanne, VD, CH 
OverviewLocationsClinical Research

Overview

Oriol Manuel is an Infectious Disease expert in Lausanne, Switzerland. Mr. Manuel is rated as an Experienced expert by MediFind in the treatment of Toxocariasis. His top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Flu, and Asymptomatic Bacteriuria.

His clinical research consists of co-authoring 204 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Toxocariasis.

Specialties
Infectious Disease
Gender
Male

Locations

Lausanne, VD, Switzerland
Other Locations
Prilly, VD, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomised Controlled Trials to Assess Approved SARS-CoV-2 Vaccines in Immunocompromised Patients: A Master Protocol for the Set-up of a Swiss Cohorts Based Trial Platform
Randomised Controlled Trials to Assess Approved SARS-CoV-2 Vaccines in Immunocompromised Patients: A Master Protocol for the Set-up of a Swiss Cohorts Based Trial Platform
Enrollment Status: Completed
Publish Date: January 25, 2024
Intervention Type: Biological
Study Drugs: Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19 Vaccine
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

204 Total Publications

Immunodeficiencies in Adults: Key Considerations for Diagnosis and Management.
Immunodeficiencies in Adults: Key Considerations for Diagnosis and Management.
Journal: Clinical reviews in allergy & immunology
Published: July 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Manuel's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile